388 related articles for article (PubMed ID: 18562481)
1. Cdc42 and RhoA have opposing roles in regulating membrane type 1-matrix metalloproteinase localization and matrix metalloproteinase-2 activation.
Ispanovic E; Serio D; Haas TL
Am J Physiol Cell Physiol; 2008 Sep; 295(3):C600-10. PubMed ID: 18562481
[TBL] [Abstract][Full Text] [Related]
2. JNK and PI3K differentially regulate MMP-2 and MT1-MMP mRNA and protein in response to actin cytoskeleton reorganization in endothelial cells.
Ispanovic E; Haas TL
Am J Physiol Cell Physiol; 2006 Oct; 291(4):C579-88. PubMed ID: 16672691
[TBL] [Abstract][Full Text] [Related]
3. Regulation of MT1-MMP and MMP-2 by leptin in cardiac fibroblasts involves Rho/ROCK-dependent actin cytoskeletal reorganization and leads to enhanced cell migration.
Schram K; Ganguly R; No EK; Fang X; Thong FS; Sweeney G
Endocrinology; 2011 May; 152(5):2037-47. PubMed ID: 21385940
[TBL] [Abstract][Full Text] [Related]
4. A novel protein associated with membrane-type 1 matrix metalloproteinase binds p27(kip1) and regulates RhoA activation, actin remodeling, and matrigel invasion.
Hoshino D; Tomari T; Nagano M; Koshikawa N; Seiki M
J Biol Chem; 2009 Oct; 284(40):27315-26. PubMed ID: 19654316
[TBL] [Abstract][Full Text] [Related]
5. Rac and Rho play opposing roles in the regulation of hypoxia/reoxygenation-induced permeability changes in pulmonary artery endothelial cells.
Wojciak-Stothard B; Tsang LY; Haworth SG
Am J Physiol Lung Cell Mol Physiol; 2005 Apr; 288(4):L749-60. PubMed ID: 15591411
[TBL] [Abstract][Full Text] [Related]
6. Endothelial lumen signaling complexes control 3D matrix-specific tubulogenesis through interdependent Cdc42- and MT1-MMP-mediated events.
Sacharidou A; Koh W; Stratman AN; Mayo AM; Fisher KE; Davis GE
Blood; 2010 Jun; 115(25):5259-69. PubMed ID: 20215637
[TBL] [Abstract][Full Text] [Related]
7. Membrane type 1-matrix metalloproteinase is regulated by chemokines monocyte-chemoattractant protein-1/ccl2 and interleukin-8/CXCL8 in endothelial cells during angiogenesis.
Gálvez BG; Genís L; Matías-Román S; Oblander SA; Tryggvason K; Apte SS; Arroyo AG
J Biol Chem; 2005 Jan; 280(2):1292-8. PubMed ID: 15516694
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor-beta-induced mobilization of actin cytoskeleton requires signaling by small GTPases Cdc42 and RhoA.
Edlund S; Landström M; Heldin CH; Aspenström P
Mol Biol Cell; 2002 Mar; 13(3):902-14. PubMed ID: 11907271
[TBL] [Abstract][Full Text] [Related]
9. Cdc42 downregulates MMP-1 expression by inhibiting the ERK1/2 pathway.
Deroanne CF; Hamelryckx D; Ho TT; Lambert CA; Catroux P; Lapière CM; Nusgens BV
J Cell Sci; 2005 Mar; 118(Pt 6):1173-83. PubMed ID: 15728253
[TBL] [Abstract][Full Text] [Related]
10. Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways: novel insights into visfatin-induced angiogenesis.
Adya R; Tan BK; Punn A; Chen J; Randeva HS
Cardiovasc Res; 2008 May; 78(2):356-65. PubMed ID: 18093986
[TBL] [Abstract][Full Text] [Related]
11. MAPK signaling regulates endothelial cell assembly into networks and expression of MT1-MMP and MMP-2.
Boyd PJ; Doyle J; Gee E; Pallan S; Haas TL
Am J Physiol Cell Physiol; 2005 Mar; 288(3):C659-68. PubMed ID: 15509661
[TBL] [Abstract][Full Text] [Related]
12. Activation of cdc42, rac, PAK, and rho-kinase in response to hepatocyte growth factor differentially regulates epithelial cell colony spreading and dissociation.
Royal I; Lamarche-Vane N; Lamorte L; Kaibuchi K; Park M
Mol Biol Cell; 2000 May; 11(5):1709-25. PubMed ID: 10793146
[TBL] [Abstract][Full Text] [Related]
13. Lysophosphatidic acid down-regulates stress fibers and up-regulates pro-matrix metalloproteinase-2 activation in ovarian cancer cells.
Do TV; Symowicz JC; Berman DM; Liotta LA; Petricoin EF; Stack MS; Fishman DA
Mol Cancer Res; 2007 Feb; 5(2):121-31. PubMed ID: 17314270
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylation of tyrosine 1214 on VEGFR2 is required for VEGF-induced activation of Cdc42 upstream of SAPK2/p38.
Lamalice L; Houle F; Jourdan G; Huot J
Oncogene; 2004 Jan; 23(2):434-45. PubMed ID: 14724572
[TBL] [Abstract][Full Text] [Related]
15. Crucial role of membrane type 1 matrix metalloproteinase (MT1- MMP) in RhoA/Rac1-dependent signaling pathways in thrombin- stimulated endothelial cells.
Ando K; Ishibashi T; Ohkawara H; Inoue N; Sugimoto K; Uekita H; Hu C; Okamoto Y; Takuwa Y; Takeishi Y
J Atheroscler Thromb; 2011; 18(9):762-73. PubMed ID: 21628952
[TBL] [Abstract][Full Text] [Related]
16. Stromal cell-derived factor-1alpha promotes melanoma cell invasion across basement membranes involving stimulation of membrane-type 1 matrix metalloproteinase and Rho GTPase activities.
Bartolomé RA; Gálvez BG; Longo N; Baleux F; Van Muijen GN; Sánchez-Mateos P; Arroyo AG; Teixidó J
Cancer Res; 2004 Apr; 64(7):2534-43. PubMed ID: 15059909
[TBL] [Abstract][Full Text] [Related]
17. Influence of actin cytoskeletal integrity on matrix metalloproteinase-2 activation in cultured human trabecular meshwork cells.
Sanka K; Maddala R; Epstein DL; Rao PV
Invest Ophthalmol Vis Sci; 2007 May; 48(5):2105-14. PubMed ID: 17460268
[TBL] [Abstract][Full Text] [Related]
18. Receptor for advanced glycation end products - membrane type1 matrix metalloproteinase axis regulates tissue factor expression via RhoA and Rac1 activation in high-mobility group box-1 stimulated endothelial cells.
Sugimoto K; Ohkawara H; Nakamura Y; Takuwa Y; Ishibashi T; Takeishi Y
PLoS One; 2014; 9(12):e114429. PubMed ID: 25490770
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Rho-dependent kinases ROCK I/II activates VEGF-driven retinal neovascularization and sprouting angiogenesis.
Kroll J; Epting D; Kern K; Dietz CT; Feng Y; Hammes HP; Wieland T; Augustin HG
Am J Physiol Heart Circ Physiol; 2009 Mar; 296(3):H893-9. PubMed ID: 19181962
[TBL] [Abstract][Full Text] [Related]
20. RhoA/ROCK-mediated switching between Cdc42- and Rac1-dependent protrusion in MTLn3 carcinoma cells.
El-Sibai M; Pertz O; Pang H; Yip SC; Lorenz M; Symons M; Condeelis JS; Hahn KM; Backer JM
Exp Cell Res; 2008 Apr; 314(7):1540-52. PubMed ID: 18316075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
